| Display title | Chemistry:Interferon beta-1b |
| Default sort key | Interferon Beta-1b |
| Page length (in bytes) | 13,532 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 526300 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>JMinHep |
| Date of page creation | 08:36, 8 February 2024 |
| Latest editor | imported>JMinHep |
| Date of latest edit | 08:36, 8 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile. |
